Wells Fargo & Company Cytokinetics Inc Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Cytokinetics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 54,108 shares of CYTK stock, worth $3.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,108
Previous 40,664
33.06%
Holding current value
$3.17 Million
Previous $2.85 Million
2.84%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding CYTK
# of Institutions
404Shares Held
126MCall Options Held
3.27MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$860 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$670 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$477 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$440 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$384 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.52B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...